154 results
144
ZNTL
Zentalis Pharmaceuticals Inc
9 May 24
Notice of proposed sale of securities
7:47pm
>
Y
The sale reported in this Form 144 was to satisfy withholding tax
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
7 May 24
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
7:03am
) before income taxes
Income tax expense
Loss on equity method investment
Net income (loss)
Net loss attributable to noncontrolling interests
Net
S-3ASR
EX-4.3
ZNTL
Zentalis Pharmaceuticals Inc
29 Feb 24
Automatic shelf registration
5:14pm
expressly permitted herein), but the Company may require payment of a sum sufficient to cover any transfer tax or similar governmental charge payable … in connection therewith (other than any such transfer tax or similar governmental charge payable upon exchanges pursuant to Sections 2.11, 3.6 or 9.6
S-3ASR
EX-1.2
9v2h93px5280eujiyxm
29 Feb 24
Automatic shelf registration
5:14pm
S-3ASR
32jh us4w
29 Feb 24
Automatic shelf registration
5:14pm
8-K
EX-99.1
gqm l9edhqa63id
27 Feb 24
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
7:04am
144
mf6fuwx8
12 Feb 24
Notice of proposed sale of securities
8:25pm
144
p204el5d7ys5b
12 Feb 24
Notice of proposed sale of securities
8:25pm
144
h740p
12 Feb 24
Notice of proposed sale of securities
8:23pm
144
klij626z gw1uq
2 Feb 24
Notice of proposed sale of securities
9:29pm